Advancing disease-modifying therapies for Parkinson's disease: Current strategies and future directions (IMAGE)
Caption
Current symptomatic treatments for Parkinson's disease—deep brain stimulation (A) and dopamine replacement therapy (B)—relieve motor symptoms without slowing disease progression. Disease-modifying strategies under exploration include directly targeting α-synuclein (C), stem cell replacement therapy (D), and mitochondrial therapy (E); targeting the neuronal receptor FAM171A2 (F) to block pathological α-synuclein transmission between neurons offers a new disease-modifying avenue.
Credit
Wu K., Zhang Y., Wang T., et al., (2026). Advancing disease-modifying therapies for Parkinson's disease: Current strategies and future directions. The Innovation 7(8), 101112.
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND